Dolutegravir
Dolutegravir market is segmented by region (country), players, by Type and by Application. Player ... Read More
1 Study Coverage 1.1 Dolutegravir Sodium Product Introduction 1.2 Global Dolutegravir Sodium Outlook 2017 VS 2022 VS 2028 1.2.1 Global Dolutegravir Sodium Sales in US$ Million for the Year 2017-2028 1.2.2 Global Dolutegravir Sodium Sales in Volume for the Year 2017-2028 1.3 United States Dolutegravir Sodium Outlook 2017 VS 2022 VS 2028 1.3.1 United States Dolutegravir Sodium Sales in US$ Million for the Year 2017-2028 1.3.2 United States Dolutegravir Sodium Sales in Volume for the Year 2017-2028 1.4 Dolutegravir Sodium Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Dolutegravir Sodium in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Dolutegravir Sodium Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Dolutegravir Sodium Market Dynamics 1.5.1 Dolutegravir Sodium Industry Trends 1.5.2 Dolutegravir Sodium Market Drivers 1.5.3 Dolutegravir Sodium Market Challenges 1.5.4 Dolutegravir Sodium Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Dolutegravir Sodium Market Segment by Type 2.1.1 Bottled Packaging 2.1.2 Film Coated Packaging 2.2 Global Dolutegravir Sodium Market Size by Type 2.2.1 Global Dolutegravir Sodium Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Dolutegravir Sodium Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Dolutegravir Sodium Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Dolutegravir Sodium Market Size by Type 2.3.1 United States Dolutegravir Sodium Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Dolutegravir Sodium Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Dolutegravir Sodium Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Dolutegravir Sodium Market Segment by Application 3.1.1 AIDS Adult Patients 3.1.2 AIDS Children over 12 Years Old 3.2 Global Dolutegravir Sodium Market Size by Application 3.2.1 Global Dolutegravir Sodium Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Dolutegravir Sodium Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Dolutegravir Sodium Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Dolutegravir Sodium Market Size by Application 3.3.1 United States Dolutegravir Sodium Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Dolutegravir Sodium Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Dolutegravir Sodium Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Dolutegravir Sodium Competitor Landscape by Company 4.1 Global Dolutegravir Sodium Market Size by Company 4.1.1 Top Global Dolutegravir Sodium Manufacturers Ranked by Revenue (2021) 4.1.2 Global Dolutegravir Sodium Revenue by Manufacturer (2017-2022) 4.1.3 Global Dolutegravir Sodium Sales by Manufacturer (2017-2022) 4.1.4 Global Dolutegravir Sodium Price by Manufacturer (2017-2022) 4.2 Global Dolutegravir Sodium Concentration Ratio (CR) 4.2.1 Dolutegravir Sodium Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dolutegravir Sodium in 2021 4.2.3 Global Dolutegravir Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Dolutegravir Sodium Manufacturing Base Distribution, Product Type 4.3.1 Global Dolutegravir Sodium Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Dolutegravir Sodium Product Type 4.3.3 Date of International Manufacturers Enter into Dolutegravir Sodium Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Dolutegravir Sodium Market Size by Company 4.5.1 Top Dolutegravir Sodium Players in United States, Ranked by Revenue (2021) 4.5.2 United States Dolutegravir Sodium Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Dolutegravir Sodium Sales by Players (2020, 2021 & 2022) 5 Global Dolutegravir Sodium Market Size by Region 5.1 Global Dolutegravir Sodium Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Dolutegravir Sodium Market Size in Volume by Region (2017-2028) 5.2.1 Global Dolutegravir Sodium Sales in Volume by Region: 2017-2022 5.2.2 Global Dolutegravir Sodium Sales in Volume Forecast by Region (2023-2028) 5.3 Global Dolutegravir Sodium Market Size in Value by Region (2017-2028) 5.3.1 Global Dolutegravir Sodium Sales in Value by Region: 2017-2022 5.3.2 Global Dolutegravir Sodium Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Dolutegravir Sodium Market Size YoY Growth 2017-2028 6.1.2 North America Dolutegravir Sodium Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Dolutegravir Sodium Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Dolutegravir Sodium Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Dolutegravir Sodium Market Size YoY Growth 2017-2028 6.3.2 Europe Dolutegravir Sodium Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Dolutegravir Sodium Market Size YoY Growth 2017-2028 6.4.2 Latin America Dolutegravir Sodium Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Dolutegravir Sodium Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Dolutegravir Sodium Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 ViiV Healthcare UK 7.1.1 ViiV Healthcare UK Corporation Information 7.1.2 ViiV Healthcare UK Description and Business Overview 7.1.3 ViiV Healthcare UK Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.1.4 ViiV Healthcare UK Dolutegravir Sodium Products Offered 7.1.5 ViiV Healthcare UK Recent Development 7.2 Emcure Pharmaceuticals 7.2.1 Emcure Pharmaceuticals Corporation Information 7.2.2 Emcure Pharmaceuticals Description and Business Overview 7.2.3 Emcure Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Emcure Pharmaceuticals Dolutegravir Sodium Products Offered 7.2.5 Emcure Pharmaceuticals Recent Development 7.3 Aurobindo Pharma 7.3.1 Aurobindo Pharma Corporation Information 7.3.2 Aurobindo Pharma Description and Business Overview 7.3.3 Aurobindo Pharma Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Aurobindo Pharma Dolutegravir Sodium Products Offered 7.3.5 Aurobindo Pharma Recent Development 7.4 LAURUS Labs 7.4.1 LAURUS Labs Corporation Information 7.4.2 LAURUS Labs Description and Business Overview 7.4.3 LAURUS Labs Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.4.4 LAURUS Labs Dolutegravir Sodium Products Offered 7.4.5 LAURUS Labs Recent Development 7.5 Mylan 7.5.1 Mylan Corporation Information 7.5.2 Mylan Description and Business Overview 7.5.3 Mylan Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Mylan Dolutegravir Sodium Products Offered 7.5.5 Mylan Recent Development 7.6 Adcock Ingram Limited 7.6.1 Adcock Ingram Limited Corporation Information 7.6.2 Adcock Ingram Limited Description and Business Overview 7.6.3 Adcock Ingram Limited Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Adcock Ingram Limited Dolutegravir Sodium Products Offered 7.6.5 Adcock Ingram Limited Recent Development 7.7 Ranbaxy Pharmaceuticals 7.7.1 Ranbaxy Pharmaceuticals Corporation Information 7.7.2 Ranbaxy Pharmaceuticals Description and Business Overview 7.7.3 Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Ranbaxy Pharmaceuticals Dolutegravir Sodium Products Offered 7.7.5 Ranbaxy Pharmaceuticals Recent Development 7.8 Cipla 7.8.1 Cipla Corporation Information 7.8.2 Cipla Description and Business Overview 7.8.3 Cipla Dolutegravir Sodium Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Cipla Dolutegravir Sodium Products Offered 7.8.5 Cipla Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Dolutegravir Sodium Industry Chain Analysis 8.2 Dolutegravir Sodium Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Dolutegravir Sodium Distributors 8.3 Dolutegravir Sodium Production Mode & Process 8.4 Dolutegravir Sodium Sales and Marketing 8.4.1 Dolutegravir Sodium Sales Channels 8.4.2 Dolutegravir Sodium Distributors 8.5 Dolutegravir Sodium Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Dolutegravir Sodium CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Dolutegravir Sodium Market Trends Table 3. Dolutegravir Sodium Market Drivers Table 4. Dolutegravir Sodium Market Challenges Table 5. Dolutegravir Sodium Market Restraints Table 6. Global Dolutegravir Sodium Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Dolutegravir Sodium Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Dolutegravir Sodium Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Dolutegravir Sodium Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Dolutegravir Sodium Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Dolutegravir Sodium Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Dolutegravir Sodium Revenue Share by Manufacturer, 2017-2022 Table 13. Global Dolutegravir Sodium Sales by Manufacturer, (K Pcs), 2017-2022 Table 14. Global Dolutegravir Sodium Sales Share by Manufacturer, 2017-2022 Table 15. Global Dolutegravir Sodium Price by Manufacturer (2017-2022) & (USD/Pcs) Table 16. Global Dolutegravir Sodium Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Dolutegravir Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dolutegravir Sodium as of 2021) Table 18. Top Players of Dolutegravir Sodium in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Dolutegravir Sodium Product Type Table 20. Date of International Manufacturers Enter into Dolutegravir Sodium Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Dolutegravir Sodium Players in United States Market, Ranking by Revenue (2021) Table 23. United States Dolutegravir Sodium Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Dolutegravir Sodium Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Dolutegravir Sodium Sales by Players, (K Pcs), 2020, 2021 & 2022 Table 26. United States Dolutegravir Sodium Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Dolutegravir Sodium Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Dolutegravir Sodium Sales in Volume by Region (2017-2022) & (K Pcs) Table 29. Global Dolutegravir Sodium Sales in Volume Forecast by Region (2023-2028) & (K Pcs) Table 30. Global Dolutegravir Sodium Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Dolutegravir Sodium Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Dolutegravir Sodium Sales in Volume by Country (2017-2028) & (K Pcs) Table 33. North America Dolutegravir Sodium Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Dolutegravir Sodium Sales in Volume by Region (2017-2028) & (K Pcs) Table 35. Asia Pacific Dolutegravir Sodium Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Dolutegravir Sodium Sales in Volume by Country (2017-2028) & (K Pcs) Table 37. Europe Dolutegravir Sodium Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Dolutegravir Sodium Sales in Volume by Country (2017-2028) & (K Pcs) Table 39. Latin Americaa Dolutegravir Sodium Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Dolutegravir Sodium Sales in Volume by Country (2017-2028) & (K Pcs) Table 41. Middle East and Africa Dolutegravir Sodium Sales in Value by Country (2017-2028) & (US$ Million) Table 42. ViiV Healthcare UK Corporation Information Table 43. ViiV Healthcare UK Description and Business Overview Table 44. ViiV Healthcare UK Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 45. ViiV Healthcare UK Dolutegravir Sodium Product Table 46. ViiV Healthcare UK Recent Development Table 47. Emcure Pharmaceuticals Corporation Information Table 48. Emcure Pharmaceuticals Description and Business Overview Table 49. Emcure Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 50. Emcure Pharmaceuticals Product Table 51. Emcure Pharmaceuticals Recent Development Table 52. Aurobindo Pharma Corporation Information Table 53. Aurobindo Pharma Description and Business Overview Table 54. Aurobindo Pharma Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 55. Aurobindo Pharma Product Table 56. Aurobindo Pharma Recent Development Table 57. LAURUS Labs Corporation Information Table 58. LAURUS Labs Description and Business Overview Table 59. LAURUS Labs Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 60. LAURUS Labs Product Table 61. LAURUS Labs Recent Development Table 62. Mylan Corporation Information Table 63. Mylan Description and Business Overview Table 64. Mylan Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 65. Mylan Product Table 66. Mylan Recent Development Table 67. Adcock Ingram Limited Corporation Information Table 68. Adcock Ingram Limited Description and Business Overview Table 69. Adcock Ingram Limited Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 70. Adcock Ingram Limited Product Table 71. Adcock Ingram Limited Recent Development Table 72. Ranbaxy Pharmaceuticals Corporation Information Table 73. Ranbaxy Pharmaceuticals Description and Business Overview Table 74. Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 75. Ranbaxy Pharmaceuticals Product Table 76. Ranbaxy Pharmaceuticals Recent Development Table 77. Cipla Corporation Information Table 78. Cipla Description and Business Overview Table 79. Cipla Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 80. Cipla Product Table 81. Cipla Recent Development Table 82. Key Raw Materials Lists Table 83. Raw Materials Key Suppliers Lists Table 84. Dolutegravir Sodium Customers List Table 85. Dolutegravir Sodium Distributors List Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Dolutegravir Sodium Product Picture Figure 2. Global Dolutegravir Sodium Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Dolutegravir Sodium Market Size 2017-2028 (US$ Million) Figure 4. Global Dolutegravir Sodium Sales 2017-2028 (K Pcs) Figure 5. United States Dolutegravir Sodium Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Dolutegravir Sodium Market Size 2017-2028 (US$ Million) Figure 7. United States Dolutegravir Sodium Sales 2017-2028 (K Pcs) Figure 8. United States Dolutegravir Sodium Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Dolutegravir Sodium Market Share in Global, in Volume (K Pcs) 2017-2028 Figure 10. Dolutegravir Sodium Report Years Considered Figure 11. Product Picture of Bottled Packaging Figure 12. Product Picture of Film Coated Packaging Figure 13. Global Dolutegravir Sodium Market Share by Type in 2022 & 2028 Figure 14. Global Dolutegravir Sodium Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Dolutegravir Sodium Sales Market Share in Value by Type (2017-2028) Figure 16. Global Dolutegravir Sodium Sales by Type (2017-2028) & (K Pcs) Figure 17. Global Dolutegravir Sodium Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Dolutegravir Sodium Price by Type (2017-2028) & (USD/Pcs) Figure 19. United States Dolutegravir Sodium Market Share by Type in 2022 & 2028 Figure 20. United States Dolutegravir Sodium Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Dolutegravir Sodium Sales Market Share in Value by Type (2017-2028) Figure 22. United States Dolutegravir Sodium Sales by Type (2017-2028) & (K Pcs) Figure 23. United States Dolutegravir Sodium Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Dolutegravir Sodium Price by Type (2017-2028) & (USD/Pcs) Figure 25. Product Picture of AIDS Adult Patients Figure 26. Product Picture of AIDS Children over 12 Years Old Figure 27. Global Dolutegravir Sodium Market Share by Application in 2022 & 2028 Figure 28. Global Dolutegravir Sodium Sales in Value by Application (2017-2028) & (US$ Million) Figure 29. Global Dolutegravir Sodium Sales Market Share in Value by Application (2017-2028) Figure 30. Global Dolutegravir Sodium Sales by Application (2017-2028) & (K Pcs) Figure 31. Global Dolutegravir Sodium Sales Market Share in Volume by Application (2017-2028) Figure 32. Global Dolutegravir Sodium Price by Application (2017-2028) & (USD/Pcs) Figure 33. United States Dolutegravir Sodium Market Share by Application in 2022 & 2028 Figure 34. United States Dolutegravir Sodium Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. United States Dolutegravir Sodium Sales Market Share in Value by Application (2017-2028) Figure 36. United States Dolutegravir Sodium Sales by Application (2017-2028) & (K Pcs) Figure 37. United States Dolutegravir Sodium Sales Market Share in Volume by Application (2017-2028) Figure 38. United States Dolutegravir Sodium Price by Application (2017-2028) & (USD/Pcs) Figure 39. North America Dolutegravir Sodium Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 40. North America Dolutegravir Sodium Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 41. U.S. Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 42. Canada Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Europe Dolutegravir Sodium Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 44. Europe Dolutegravir Sodium Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 45. Germany Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. France Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. U.K. Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Italy Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Russia Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Asia-Pacific Dolutegravir Sodium Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 51. Asia-Pacific Dolutegravir Sodium Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 52. China Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Japan Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. South Korea Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. India Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Australia Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Taiwan Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Indonesia Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Thailand Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Malaysia Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Philippines Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Latin America Dolutegravir Sodium Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 63. Latin America Dolutegravir Sodium Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 64. Mexico Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Brazil Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Argentina Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Middle East & Africa Dolutegravir Sodium Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 68. Middle East & Africa Dolutegravir Sodium Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 69. Turkey Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Saudi Arabia Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. U.A.E Dolutegravir Sodium Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Dolutegravir Sodium Value Chain Figure 73. Dolutegravir Sodium Production Process Figure 74. Channels of Distribution Figure 75. Distributors Profiles Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed
ViiV Healthcare UK Emcure Pharmaceuticals Aurobindo Pharma LAURUS Labs Mylan Adcock Ingram Limited Ranbaxy Pharmaceuticals Cipla
Dolutegravir market is segmented by region (country), players, by Type and by Application. Player ... Read More
Raltegravir Potassium market is segmented by region (country), players, by Type and by Applicatio ... Read More
Tenofovir Disoproxil Fumarate market is segmented by region (country), players, by Type and by Ap ... Read More
Palbociclib market is segmented by region (country), players, by Type and by Application. Players ... Read More